Literature DB >> 19053053

Visual scanning and cognitive performance in prediagnostic and early-stage Huntington's disease.

Tanya Blekher1, Marjorie R Weaver, Jeanine Marshall, Siu Hui, Jacqueline Gray Jackson, Julie C Stout, Xabier Beristain, Joanne Wojcieszek, Robert D Yee, Tatiana M Foroud.   

Abstract

The objective of this study was to evaluate visual scanning strategies in carriers of the Huntington disease (HD) gene expansion and to test whether there is an association between measures of visual scanning and cognitive performance. The study sample included control (NC, n = 23), prediagnostic (PDHD, n = 21), and subjects recently diagnosed with HD (HD, n = 19). All participants completed a uniform clinical evaluation that included examination by neurologist and molecular testing. Eye movements were recorded during completion of the Digit Symbol Subscale (DS) test. Quantitative measures of the subject's visual scanning were evaluated using joint analysis of eye movements and performance on the DS test. All participants employed a simple visual scanning strategy when completing the DS test. There was a significant group effect and a linear trend of decreasing frequency and regularity of visual scanning from NC to PDHD to HD. The performance of all groups improved slightly and in a parallel fashion across the duration of the DS test. There was a strong correlation between visual scanning measures and the DS cognitive scores. While all individuals employed a similar visual scanning strategy, the visual scanning measures grew progressively worse from NC to PDHD to HD. The deficits in visual scanning accounted, at least in part, for the decrease in the DS score.

Entities:  

Mesh:

Year:  2009        PMID: 19053053      PMCID: PMC2834211          DOI: 10.1002/mds.22329

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  28 in total

1.  Clinical markers of early disease in persons near onset of Huntington's disease.

Authors:  J S Paulsen; H Zhao; J C Stout; R R Brinkman; M Guttman; C A Ross; P Como; C Manning; M R Hayden; I Shoulson
Journal:  Neurology       Date:  2001-08-28       Impact factor: 9.910

2.  Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease.

Authors:  E H Aylward; A M Codori; A Rosenblatt; M Sherr; J Brandt; O C Stine; P E Barta; G D Pearlson; C A Ross
Journal:  Mov Disord       Date:  2000-05       Impact factor: 10.338

3.  Cognitive and motor functioning in gene carriers for Huntington's disease: a baseline study.

Authors:  Marie-Noëlle W Witjes-Ané; Maria Vegter-van der Vlis; Jeroen P P van Vugt; Jan B K Lanser; Jo Hermans; Aeilko H Zwinderman; Gert-Jan B van Ommen; Raymund A C Roos
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2003       Impact factor: 2.198

4.  Brain structure in preclinical Huntington's disease.

Authors:  Jane S Paulsen; Vince A Magnotta; Ania E Mikos; Henry L Paulson; Elizabeth Penziner; Nancy C Andreasen; Peg C Nopoulos
Journal:  Biol Psychiatry       Date:  2005-08-22       Impact factor: 13.382

5.  Identification of an oculomotor biomarker of preclinical Huntington disease.

Authors:  C V P Golding; C Danchaivijitr; T L Hodgson; S J Tabrizi; C Kennard
Journal:  Neurology       Date:  2006-04-19       Impact factor: 9.910

6.  Regional and progressive thinning of the cortical ribbon in Huntington's disease.

Authors:  H D Rosas; A K Liu; S Hersch; M Glessner; R J Ferrante; D H Salat; A van der Kouwe; B G Jenkins; A M Dale; B Fischl
Journal:  Neurology       Date:  2002-03-12       Impact factor: 9.910

7.  Psychomotor, executive, and memory function in preclinical Huntington's disease.

Authors:  J S Snowden; D Craufurd; J Thompson; D Neary
Journal:  J Clin Exp Neuropsychol       Date:  2002-04       Impact factor: 2.475

8.  Saccades in presymptomatic and early stages of Huntington disease.

Authors:  T Blekher; S A Johnson; J Marshall; K White; S Hui; M Weaver; J Gray; R Yee; J C Stout; X Beristain; J Wojcieszek; T Foroud
Journal:  Neurology       Date:  2006-07-19       Impact factor: 9.910

9.  Preclinical Huntington's disease: compensatory brain responses during learning.

Authors:  Andrew Feigin; Maria-Felice Ghilardi; Chaorui Huang; Yilong Ma; Maren Carbon; Mark Guttman; Jane S Paulsen; Claude P Ghez; David Eidelberg
Journal:  Ann Neurol       Date:  2006-01       Impact factor: 10.422

10.  Proximity to clinical onset influences motor and cognitive performance in presymptomatic Huntington disease gene carriers.

Authors:  Maree Farrow; Phyllis Chua; Andrew Churchyard; John L Bradshaw; Edmond Chiu; Nellie Georgiou-Karistianis
Journal:  Cogn Behav Neurol       Date:  2006-12       Impact factor: 1.600

View more
  5 in total

1.  Behavioral measures of saccade latency and inhibition in manifest and premanifest Huntington's disease.

Authors:  Travis H Turner; Jody Goldstein; Joanne M Hamilton; Mark Jacobson; Eva Pirogovsky; Guerry Peavy; Jody Corey-Bloom
Journal:  J Mot Behav       Date:  2011-06-24       Impact factor: 1.328

2.  Putting things into perspective: the nature and impact of theory of mind impairment in Huntington's disease.

Authors:  Clare M Eddy; Sridevi Sira Mahalingappa; Hugh E Rickards
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-03-20       Impact factor: 5.270

3.  Huntington's disease from the patient, caregiver and physician's perspectives: three sides of the same coin?

Authors:  Krzysztof Banaszkiewicz; Emilia J Sitek; Monika Rudzińska; Witold Sołtan; Jarosław Sławek; Andrzej Szczudlik
Journal:  J Neural Transm (Vienna)       Date:  2012-03-08       Impact factor: 3.575

4.  Scanning Patterns of Faces do not Explain Impaired Emotion Recognition in Huntington Disease: Evidence for a High Level Mechanism.

Authors:  Marieke van Asselen; Filipa Júlio; Cristina Januário; Elzbieta Bobrowicz Campos; Inês Almeida; Sara Cavaco; Miguel Castelo-Branco
Journal:  Front Psychol       Date:  2012-02-16

5.  Abnormal Visual Scanning of Emotionally Evocative Natural Scenes in Huntington's Disease.

Authors:  Catarina C Kordsachia; Izelle Labuschagne; Julie C Stout
Journal:  Front Psychol       Date:  2017-03-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.